Virtual screening and network pharmacology-based synergistic mechanism identification of multiple components contained in Guanxin V against coronary artery disease
Abstract Background Guanxin V (GXV), a traditional Chinese medicine (TCM), has been widely used to treat coronary artery disease (CAD) in clinical practice in China. However, research on the active components and underlying mechanisms of GXV in CAD is still scarce. Methods A virtual screening and ne...
Saved in:
Main Authors: | Bo Liang (Author), Xiao-Xiao Zhang (Author), Ning Gu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Guanxin V in animal model of acute myocardial infarction
by: Xiaoxiao Zhang, et al.
Published: (2021) -
Guanxinning for Residual Inflammation of Stable Coronary Artery Disease: A Pilot Randomized Controlled Trial
by: Chen T, et al.
Published: (2024) -
Identification of Pharmacokinetic Markers for Guanxin Danshen Drop Pills in Rats by Combination of Pharmacokinetics, Systems Pharmacology, and Pharmacodynamic Assays
by: Hong Yao, et al.
Published: (2018) -
Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish
by: Jun Li, et al.
Published: (2021) -
Study of the Mechanism of Action of Guanxin Shutong Capsules in the Treatment of Coronary Heart Disease Based on Metabolomics
by: Dan Wang, et al.
Published: (2021)